ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain (NCT07568015)
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain: A Multi-Center, Randomized, Controlled Trial (RENEU)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to evaluate the safety and analgesic performance of the ReneuRx™ device in subjects with moderate to severe chronic lateral hip pain compared to subjects receiving treatment with corticosteroid injection in adults aged 22-80 years. Participants will attend study visits and complete quality of life questionnaires. Participants will be followed for approximately 6-12 months after the study procedure.
Who can join: Review the eligibility criteria below.
Location: Healthcare Outcomes Performance Company — Sun City, Arizona
Age range: 22 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- Healthcare Outcomes Performance Company — Sun City, Arizona
- Emory Orthopedics and Spine Center — Johns Creek, Georgia
- Ochsner Health Center — New Orleans, Louisiana
- Skylight Health Research — Burlington, Massachusetts
- Mass General Brigham — Chestnut Hill, Massachusetts
- Virtua Health — Sewell, New Jersey
- The Orthopaedic Center — Tulsa, Oklahoma
- Rothman Orthopaedics — King of Prussia, Pennsylvania
- Pain Diagnostics & Interventional Care — Sewickley, Pennsylvania
- University of Texas Southwestern Medical Center — Dallas, Texas
- All-American Orthopedic & Sports — Houston, Texas
📞 Contact the Study Coordinator
Phone: (314) 480-2244
Email: david.curd@brixtonbio.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Greater Trochanteric Pain Syndrome
- Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS) — The Bronx, New York
Explore by condition: All Greater Trochanteric Pain Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.